Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Share News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 75.00
Ask: 90.00
Change: 0.00 (0.00%)
Spread: 15.00 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.50
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Feedback secures funding for Oldham pilot

Thu, 21st Mar 2024 16:21

(Sharecast News) - Feedback has secured £50,000 in funding to initiate a Community Diagnostic Centre (CDC) pathway pilot with the Oldham CDC, it announced on Thursday, managed by the Northern Care Alliance.

The AIM-traded firm said the funding, obtained under NHS England's CDC programme, came after successful pilots at the Amersham CDC in Buckinghamshire and a pan-regional pilot across Buckinghamshire, Oxfordshire, and Berkshire ICS, as it announced on 19 December.

Under the new contract, Feedback would provide advisory services to the Oldham CDC until 31 March, focusing on pathways development and deploying its leading symptom-based pathway tool, Bleepa.

On meeting initial milestones, Feedback would assist Oldham CDC in seeking additional funding from the 2024-2025 NHS budget to expand the pilot.

The aim was to integrate Bleepa and establish a live breathlessness pathway for patients, drawing insights from ongoing pilots at Amersham CDC and BOB ICS.

That expansion followed the success of the ongoing breathlessness pathway pilot at Queen Victoria Hospital (QVH) and the Sussex Integrated Care System (Sussex ICS).

"We are gaining momentum in the CDC space following the funding support released by NHSE," said chief executive officer Dr Tom Oakley.

"Each additional site builds the evidence base for wider rollout and helps convince the wider NHS of the unquestionable benefits of the symptom-based, straight-to-diagnostic pathway approach.

"A national conversation is growing around how CDCs can be used to drive down waitlists and demonstrates how the NHS can achieve a return on their capital investments to date in building CDCs."

Dr Oakley said that was about leveraging the diagnostic outputs of the CDC to drive down waitlists by integrating them into patient pathways.

"We are focussed on further demonstrating the impact of a pathway approach on CDC utilisation and wider patient wait times - by providing multiple service lines and mutual aid delivery models for sharing workforce capacity at a regional basis through the Bleepa platform.

"We continue to have a number of discussions at the local, regional and national levels with NHS bodies and anticipate further updates in the coming months.

"Furthermore, we are encouraged by the increased NHS spending announced in the Spring Budget, highlighting the importance of investing in digital capabilities for the UK healthcare system."

At 1325 GMT, shares in Feedback were down 4.16% at 115.01p.

Reporting by Josh White for Sharecast.com.

More News
6 Oct 2015 09:05

Feedback Shares Gain As NHS Research Arm Publishes Notice On TexRAD

Read more
5 Oct 2015 09:31

Feedback PLC forms cancer diagnosis joint venture

(ShareCast News) - Medical imaging software company Feedback PLC announced the incorporation of a joint venture company, Prostate Checker, with Spain's QUIBIM, to develop a product for the detection and diagnosis of prostate cancer. Feedback said that in order to facilitate this move, it has granted

Read more
5 Oct 2015 07:24

Feedback Forms Prostate Cancer Diagnosis Joint Venture With Quibim

Read more
28 Sep 2015 09:08

Feedback Inks Urology Application Deals For TexRAD Software

Read more
9 Sep 2015 08:39

Feedback receives first TexRAD order

(ShareCast News) - Feedback, the medical imaging software producer, has received the first order for its TexRAD texture analysis software. The group said Peking Union Medical College Hospital in Beijing bought the software, adding it will use it to undertake research studies into cancer and other di

Read more
9 Sep 2015 06:55

Feedback Secures First TexRAD Software Order From China

Read more
20 Jul 2015 07:13

Feedback Shares Higher After Positive TexRAD Study Results

Read more
6 Jul 2015 13:12

Feedback Issues 216,000 Shares At 1.25 Pence To PR Adviser (ALLISS)

Read more
12 Jun 2015 09:46

Feedback receives first Canadian order for TexRad

Medical imaging software company Feedback has received its first server sale of its TexRad texture analysis software in Canada. The software will be installed in the Department of Diagnostic Radiology at the McGill University Health Centre, where it will be used in a research study of breast cancer

Read more
12 Jun 2015 08:13

Feedback Gets First Order For TexRad Software In Canada

Read more
4 Jun 2015 11:30

LONDON MIDDAY BRIEFING: Johnson Matthey Hit By Mixed Outlook

Read more
4 Jun 2015 10:47

WINNERS & LOSERS: EasyJet Rises On Strong May Traffic Statistics

Read more
4 Jun 2015 09:58

Feedback unclear about reason for jump in share price

Medical imaging software company Feedback was performing strongly on Thursday morning, but said it was unaware of any reason, other than Wednesday's successful placing, as to why shares had jumped so much. The share price, trading volume and speculation on the bulletin boards all saw an increase. T

Read more
4 Jun 2015 09:04

Feedback Knows Of No Reason For 40% Share Price Jump

Read more
3 Jun 2015 07:00

Feedback Raises GBP200,000 In Placing To Fund TexRAD Development (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.